Patent ID: 9493426
Filing Date: 2016-11-15
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A compound selected from the group consisting of a compound of formula (I) a tautomeric form, stereochemically isomeric form and isotopic form thereof, wherein W is —N(R each R wherein R D represents a 3 to 12 ring membered monocyclic or bicyclic carbocyclyl or a 3 to 12 ring membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O or S, wherein said carbocyclyl and heterocyclyl may each be optionally substituted by one or more R R R R R wherein ring A is a monocyclic 5 to 7 membered saturated heterocycle containing one heteroatom selected from N, O or S, said heteroatom not being positioned in alpha position of the double bond, wherein ring A is optionally being substituted with cyano, C 1-4 alkyl, hydroxyC 1-4 alkyl, H 2 N—C 1-4 alkyl, (C 1-4 alkyl)NH—C 1-4 alkyl, (C 1-4 alkyl) 2 N—C 1-4 alkyl, (haloC 1-4 alkyl)NH—C 1-4 alkyl, C 1-4 alkoxyC 1-4 alkyl, —C(═O)—NH 2 , —C(═O)—NH(C 1-4 alkyl), —C(═O)—N(C 1-4 alkyl) 2 ; R R R R R R C or when two of the substituents of R R R R R R n independently represents an integer equal to 0, 1, 2, 3 or 4; or an N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof.